Chronic hepatitis B virus infection is common cause of morbidity and mortality in resource poor settings. Now that effective drugs are available, international action is needed to implement treatment programmes.
No takes yet. Share an insight, caveat, or question.
Thursz et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: